MedPath
NMPA Approval

Lomefloxacin Aspartate Injection

国药准字H20058222

November 3, 2020

Drug Information

门冬氨酸洛美沙星注射液

注射剂

2ml:0.1g(以C17H19F2N3O3计)

化学药品

November 3, 2020

Company Information

Applicant Company

衡水市冀州区永兴西路588号

Manufacturing Company

衡水市开发区新区六路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬氨酸洛美沙星注射液 - NMPA 批准文号 | MedPath